LEPESTC Analysis
“LEPESTC” Analysis
LEPESTC News of Local & International
1. International News of Legal Environment
Flupentixol with Melitracen Banned in the India
India’s ministry of health and family welfare has banned the popular diabetes drug pioglitazone, the painkiller metamizole, and the psychiatric combination flupentixol with melitracen with immediate effect, because it said that their use was “likely to involve risk to human beings.
This is due to its potentially serious neurological side effects.
News
MUMBAI: The government has banned three popular medicines—the widely prescribed anti-diabetes drug pioglitazone, painkiller analgin and anti-depressant deanxit—in the wake of health risks associated with them. While it's believed that pioglitazone can cause heart failure and increases the risk of bladder cancer, analgin has been discarded the world over on grounds of patient safety. Deanxit, on the other hand is a harmful combination, which has been long banned even in Denmark, its country of origin.
This decision comes in the wake of a strong stand by the government on suspending marketing of all drugs prohibited for sale in other countries like the US, the UK, EU and Australia.
The ministry of health and family welfare has suspended the manufacture and sale of all three drugs under Section 26A of the Drugs and Cosmetics Act, 1940 with immediate effect, through a notification issued on June 18, informed sources told TOI. While the ministry has been dilly-dallying on withdrawing analgin and deanxit for years now, despite pressure from a parliamentary panel, the decision on the diabetes drug pioglitazone has taken the industry completely by surprise.
Published: Jun 27, 2013, 05.16AM
Source: http://timesofindia.indiatimes.com/india/Govt-bans-popular-diabetes-drug-and-analgin/articleshow/20789831.cms
2. Local News of Legal Environment
Pay by Sunday or face legal action
State minister Mujibul Haque Chunnu warns Tuba owners
News
The government will take legal
LEPESTC News of Local & International
1. International News of Legal Environment
Flupentixol with Melitracen Banned in the India
India’s ministry of health and family welfare has banned the popular diabetes drug pioglitazone, the painkiller metamizole, and the psychiatric combination flupentixol with melitracen with immediate effect, because it said that their use was “likely to involve risk to human beings.
This is due to its potentially serious neurological side effects.
News
MUMBAI: The government has banned three popular medicines—the widely prescribed anti-diabetes drug pioglitazone, painkiller analgin and anti-depressant deanxit—in the wake of health risks associated with them. While it's believed that pioglitazone can cause heart failure and increases the risk of bladder cancer, analgin has been discarded the world over on grounds of patient safety. Deanxit, on the other hand is a harmful combination, which has been long banned even in Denmark, its country of origin.
This decision comes in the wake of a strong stand by the government on suspending marketing of all drugs prohibited for sale in other countries like the US, the UK, EU and Australia.
The ministry of health and family welfare has suspended the manufacture and sale of all three drugs under Section 26A of the Drugs and Cosmetics Act, 1940 with immediate effect, through a notification issued on June 18, informed sources told TOI. While the ministry has been dilly-dallying on withdrawing analgin and deanxit for years now, despite pressure from a parliamentary panel, the decision on the diabetes drug pioglitazone has taken the industry completely by surprise.
Published: Jun 27, 2013, 05.16AM
Source: http://timesofindia.indiatimes.com/india/Govt-bans-popular-diabetes-drug-and-analgin/articleshow/20789831.cms
2. Local News of Legal Environment
Pay by Sunday or face legal action
State minister Mujibul Haque Chunnu warns Tuba owners
News
The government will take legal